ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder

This study has been completed.
Study NCT00001381.   Last updated on March 3, 2008.   Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Bladder Neoplasms
Carcinoma, Transitional Cell
2 Additional conditions recognized in this trial
Carcinoma
Urinary Bladder Neoplasms
3 More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Urinary Bladder Diseases
Urogenital Neoplasms
Urologic Diseases
Urologic Neoplasms
4 Interventions listed in this trial
suramin
5 More general drug interventions related to this trial
Anthelmintics
Anti-Infective Agents
Antinematodal Agents
Antineoplastic Agents
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Therapeutic Uses
Trypanocidal Agents
6 Sponsors listed in this trial
National Cancer Institute (NCI)




Links to all studies - primarily for crawlers